Check nearby libraries
Buy this book

Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children--50 to 75 percent-- have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.
Check nearby libraries
Buy this book

Subjects
Law and legislation, Pediatrics, Drug Evaluation, Drugs, Pediatric pharmacology, Testing, Research, Congresses, Standards, Drugs, testingPlaces
United StatesEdition | Availability |
---|---|
1
Addressing the Barriers to Pediatric Drug Development: Workshop Summary
2009, National Academies Press
in English
1281800236 9781281800237
|
aaaa
|
2
Addressing the barriers to pediatric drug development: workshop summary
2008, National Academies Press
in English
0309107423 9780309107426
|
zzzz
|
3
Addressing the barriers to pediatric drug development: workshop summary
2008, National Academies Press
in English
0309107423 9780309107426
|
zzzz
|
Book Details
Classifications
Edition Identifiers
Work Identifiers
Community Reviews (0)
History
- Created September 17, 2024
- 1 revision
Wikipedia citation
×CloseCopy and paste this code into your Wikipedia page. Need help?
September 17, 2024 | Created by ImportBot | Imported from Better World Books record |